PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
H3P9 |
|
H3 histone pseudogene 9
|
|
|
0.505 |
0.731 |
HDL3 |
|
Huntington-like neurodegenerative disorder 2
|
|
|
0.663 |
0.423 |
TNFRSF11B |
O00300
|
TNF receptor superfamily member 11b
|
|
0.16 |
0.422 |
0.808 |
PIK3C2A |
O00443
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha
|
Kinase
|
1.0E-02 |
0.633 |
0.692 |
TNFSF11 |
O14788
|
TNF superfamily member 11
|
Signaling
|
4.9E-03 |
0.453 |
0.846 |
KCNN4 |
O15554
|
potassium calcium-activated channel subfamily N member 4
|
Ion channel
|
5.0E-07 |
0.653 |
0.577 |
JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
PTP4A3 |
O75365
|
protein tyrosine phosphatase 4A3
|
|
4.5E-02 |
0.566 |
0.654 |
SORBS2 |
O94875
|
sorbin and SH3 domain containing 2
|
|
3.6E-02 |
0.736 |
0.423 |
ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
LDLR |
P01130
|
low density lipoprotein receptor
|
|
9.8E-24 |
0.449 |
0.885 |
PRL |
P01236
|
prolactin
|
Signaling
|
2.9E-07 |
0.406 |
0.885 |
APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
SMR3B |
P02814
|
submaxillary gland androgen regulated protein 3B
|
|
0.39 |
0.601 |
0.654 |
APOB |
P04114
|
apolipoprotein B
|
|
1.9E-16 |
0.453 |
0.808 |
MPO |
P05164
|
myeloperoxidase
|
Enzyme
|
7.1E-15 |
0.377 |
0.923 |
NPM1 |
P06748
|
nucleophosmin 1
|
Chaperone
|
1.00 |
0.464 |
0.846 |
FABP1 |
P07148
|
fatty acid binding protein 1
|
|
9.8E-07 |
0.588 |
0.692 |
MT1B |
P07438
|
metallothionein 1B
|
|
5.4E-03 |
0.585 |
0.731 |
LGALS1 |
P09382
|
galectin 1
|
Signaling
|
4.5E-03 |
0.435 |
0.846 |
MYB |
P10242
|
MYB proto-oncogene, transcription factor
|
|
0.82 |
0.490 |
0.692 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |